PD31-06 UPDATED LONG-TERM SURVIVAL AND SAFETY FROM A MULTI-CENTER, OPEN-LABEL, PIVOTAL PHASE 2 STUDY OF AZEDRA® IN PATIENTS WITH UNRESECTABLE, LOCALLY ADVANCED OR METASTATIC PHEOCHROMOCYTOMA OR PARAGANGLIOMA

Abstract

Peer reviewed

Camilo Jimenez, Bennett B. Chin, Richard B. Noto, Joseph S. Dillon, Lilja Solnes, Vincent A. DiPippo, Nancy Stambler, Vivien Wong and Daniel A. Pryma

The Journal of urology, Vol.203, p.e632

04/2020

DOI: 10.1097/JU.0000000000000895.06

View Online

Title: Subtitle: PD31-06 UPDATED LONG-TERM SURVIVAL AND SAFETY FROM A MULTI-CENTER, OPEN-LABEL, PIVOTAL PHASE 2 STUDY OF AZEDRA® IN PATIENTS WITH UNRESECTABLE, LOCALLY ADVANCED OR METASTATIC PHEOCHROMOCYTOMA OR PARAGANGLIOMA
Creators: Camilo Jimenez
Bennett B. Chin
Richard B. Noto
Joseph S. Dillon
Lilja Solnes
Vincent A. DiPippo
Nancy Stambler
Vivien Wong
Daniel A. Pryma
Resource Type: Abstract
Publication Details: The Journal of urology, Vol.203, p.e632
DOI: 10.1097/JU.0000000000000895.06
ISSN: 0022-5347
eISSN: 1527-3792
Language: English
Date published: 04/2020
Academic Unit: Endocrinology and Metabolism; Fraternal Order of Eagles Diabetes Research Center; Internal Medicine
Record Identifier: 9984361561802771

3 Record Views